Masimo ROA 2007-2018 | MASI
Current and historical return on assets (ROA) values for Masimo (MASI) over the last 10 years.
| Masimo Annual ROA - Return on Assets | |
|---|---|
| 2017 | 14.46 |
| 2016 | 36.64 |
| 2015 | 13.54 |
| 2014 | 13.16 |
| 2013 | 12.70 |
| 2012 | 16.53 |
| 2011 | 17.50 |
| 2010 | 23.66 |
| 2009 | 15.16 |
| 2008 | 10.88 |
| 2007 | 17.94 |
| 2006 | 114.30 |
| 2005 | 0.00 |
| Masimo Quarterly ROA - Return on Assets | |
|---|---|
| Q2 2018 | 4.35 |
| Q1 2018 | 4.81 |
| Q4 2017 | -0.47 |
| Q3 2017 | 4.33 |
| Q2 2017 | 5.04 |
| Q1 2017 | 5.87 |
| Q4 2016 | 26.24 |
| Q3 2016 | 4.34 |
| Q2 2016 | 4.98 |
| Q1 2016 | 4.44 |
| Q4 2015 | 4.16 |
| Q3 2015 | 3.10 |
| Q2 2015 | 3.20 |
| Q1 2015 | 3.45 |
| Q4 2014 | 3.86 |
| Q3 2014 | 3.03 |
| Q2 2014 | 2.80 |
| Q1 2014 | 4.90 |
| Q4 2013 | 2.09 |
| Q3 2013 | 3.62 |
| Q2 2013 | 3.69 |
| Q1 2013 | 4.23 |
| Q4 2012 | 3.96 |
| Q3 2012 | 3.31 |
| Q2 2012 | 4.66 |
| Q1 2012 | 4.15 |
| Q4 2011 | 3.87 |
| Q3 2011 | 3.96 |
| Q2 2011 | 4.81 |
| Q1 2011 | 5.54 |
| Q4 2010 | 5.36 |
| Q3 2010 | 5.11 |
| Q2 2010 | 4.63 |
| Q1 2010 | 8.98 |
| Q4 2009 | 3.98 |
| Q3 2009 | 3.97 |
| Q2 2009 | 4.20 |
| Q1 2009 | 4.35 |
| Q4 2008 | -0.18 |
| Q3 2008 | 4.82 |
| Q2 2008 | 4.23 |
| Q1 2008 | 3.87 |
| Q4 2007 | 5.12 |
| Q3 2007 | 4.70 |
| Q2 2007 | 6.06 |
| Q1 2007 | 0.00 |
| Q3 2006 | 0.00 |
| Q2 2006 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $5.813B | $0.798B |
| Masimo Corporation is a global medical technology company that develops and manufactures innovative noninvasive patient monitoring technologies, medical devices, and a wide array of sensors. They believe that Masimo SET helps clinicians monitor in excess of approximately million patients in healthcare settings around the world, and is the pulse oximeter technology used by the top hospitals. Masimo as a private `garage start-up` company because they convinced that the use of adaptive signal processing in the measurement of physiological parameters could solve the problems of low perfusion and motion, which had long plagued in-vivo monitoring and especially pulse oximetry, the measurement of the oxygen saturation of arterial blood. His solution, Masimo SET Measure-through Motion and Low Perfusion pulse oximetry, was shown in a study comparing three pulse oximetry technologies to demonstrate the highest sensitivity and specificity in identifying desaturation events during conditions of motion and low perfusion. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $92.240B | 22.13 |
| Intuitive Surgical (ISRG) | United States | $59.464B | 56.76 |
| Fresenius Medical Care (FMS) | Germany | $29.150B | 20.59 |
| Edwards Lifesciences (EW) | United States | $28.868B | 32.52 |
| IDEXX Laboratories (IDXX) | United States | $20.918B | 63.57 |
| ABIOMED (ABMD) | United States | $16.317B | 133.67 |
| DexCom (DXCM) | United States | $10.947B | 0.00 |
| Teleflex (TFX) | United States | $10.762B | 25.60 |
| Hologic (HOLX) | United States | $10.452B | 17.78 |
| Varian Medical Systems (VAR) | United States | $10.008B | 25.19 |
| STERIS (STE) | United Kingdom | $9.554B | 26.28 |
| LivaNova (LIVN) | United Kingdom | $5.902B | 35.21 |
| Integra LifeSciences Holdings (IART) | United States | $5.279B | 27.32 |
| Globus Medical (GMED) | United States | $5.081B | 33.80 |
| Inogen (INGN) | United States | $4.882B | 129.19 |
| Penumbra (PEN) | United States | $4.258B | 387.03 |
| Cantel Medical (CMD) | United States | $3.939B | 41.06 |
| Halyard Health (AVNS) | United States | $2.974B | 24.47 |
| Opko Health (OPK) | United States | $2.944B | 0.00 |
| Wright Medical Group (WMGI) | Netherlands | $2.910B | 0.00 |
| Integer Holdings (ITGR) | United States | $2.201B | 19.93 |
| Nevro (NVRO) | United States | $1.868B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.757B | 0.00 |
| AxoGen (AXGN) | United States | $1.408B | 0.00 |
| Glaukos (GKOS) | United States | $1.379B | 790.00 |
| Natus Medical (BABY) | United States | $1.224B | 25.96 |
| Luminex (LMNX) | United States | $1.201B | 35.43 |
| Accelerate Diagnostics (AXDX) | United States | $1.180B | 0.00 |
| CryoLife (CRY) | United States | $1.179B | 103.39 |
| Mazor Robotics (MZOR) | Israel | $1.131B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $1.056B | 180.00 |
| TransEnterix (TRXC) | United States | $0.917B | 0.00 |
| K2Ms (KTWO) | United States | $0.875B | 0.00 |
| Intersect ENT (XENT) | United States | $0.813B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.794B | 29.49 |
| Mesa Laboratories (MLAB) | United States | $0.790B | 48.90 |
| ViewRay (VRAY) | United States | $0.727B | 0.00 |
| Sientra (SIEN) | United States | $0.597B | 0.00 |
| Neuronetics (STIM) | United States | $0.574B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.565B | 0.00 |
| Veracyte (VCYT) | United States | $0.418B | 0.00 |
| GenMark Diagnostics (GNMK) | United States | $0.401B | 0.00 |
| Quotient (QTNT) | Switzerland | $0.390B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.371B | 0.00 |
| Oxford Immunotec Global (OXFD) | United Kingdom | $0.366B | 0.00 |
| IRadimed (IRMD) | United States | $0.299B | 107.69 |
| Accuray (ARAY) | United States | $0.298B | 0.00 |
| RTI Surgical (RTIX) | United States | $0.288B | 56.88 |
| T2 Biosystems (TTOO) | United States | $0.287B | 0.00 |
| Fluidigm (FLDM) | United States | $0.273B | 0.00 |
| Nuvectra (NVTR) | United States | $0.270B | 0.00 |
| CRH Medical (CRHM) | Canada | $0.258B | 32.27 |
| Pulse Biosciences (PLSE) | United States | $0.246B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.222B | 0.00 |
| SeaSpine Holdings (SPNE) | United States | $0.201B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.186B | 0.00 |
| Corindus Vascular Robotics (CVRS) | United States | $0.166B | 0.00 |
| Apollo Endosurgery (APEN) | United States | $0.165B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $0.140B | 0.00 |
| Second Sight Medical Products (EYES) | United States | $0.101B | 0.00 |
| Viveve Medical (VIVE) | United States | $0.099B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.096B | 0.00 |
| HTG Molecular Diagnostics (HTGM) | United States | $0.094B | 0.00 |
| EDAP TMS (EDAP) | France | $0.091B | 0.00 |
| Invuity (IVTY) | United States | $0.082B | 0.00 |
| Xtant Medical Holdings (XTNT) | United States | $0.081B | 0.00 |
| Neovasc (NVCN) | Canada | $0.066B | 0.00 |
| ConforMIS (CFMS) | United States | $0.057B | 0.00 |
| Restoration Robotics (HAIR) | United States | $0.050B | 0.00 |
| Electromed (ELMD) | United States | $0.043B | 23.64 |
| Vermillion (VRML) | United States | $0.039B | 0.00 |
| PAVmed (PAVM) | United States | $0.037B | 0.00 |
| Presbia (LENS) | Ireland | $0.036B | 0.00 |
| ReWalk Robotics (RWLK) | Israel | $0.033B | 0.00 |
| OBALON THERPTCS (OBLN) | United States | $0.032B | 0.00 |
| Lianluo Smart (LLIT) | China | $0.028B | 0.00 |
| Titan Medical (TMDI) | Canada | $0.025B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.025B | 0.00 |
| DarioHealth (DRIO) | Israel | $0.024B | 0.00 |
| Dynatronics (DYNT) | United States | $0.023B | 0.00 |
| Navidea Biopharmaceuticals (NAVB) | United States | $0.022B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.018B | 0.00 |
| American Shared Hospital Services (AMS) | United States | $0.017B | 13.64 |
| Bioanalytical Systems (BASI) | United States | $0.015B | 0.00 |
| Allied Healthcare Products (AHPI) | United States | $0.010B | 0.00 |
| Micron Solutions (MICR) | United States | $0.010B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.009B | 0.00 |
| Sunshine Heart Inc (CHFS) | United States | $0.007B | 0.00 |
| Avinger (AVGR) | United States | $0.006B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.006B | 0.00 |
| Cesca Therapeutics (KOOL) | United States | $0.006B | 0.00 |
| InspireMD (NSPR) | Israel | $0.005B | 0.00 |
| Amedica (AMDA) | United States | $0.002B | 0.00 |
| EnteroMedics (RSLS) | United States | $0.001B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.000B | 0.00 |
